Perrine Créquit

1.2k total citations
44 papers, 709 citations indexed

About

Perrine Créquit is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Perrine Créquit has authored 44 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Economics and Econometrics. Recurrent topics in Perrine Créquit's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Meta-analysis and systematic reviews (8 papers). Perrine Créquit is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers) and Meta-analysis and systematic reviews (8 papers). Perrine Créquit collaborates with scholars based in France, United States and United Kingdom. Perrine Créquit's co-authors include Philippe Ravaud, Alexandre Vivot, Ludovic Trinquart, Raphaël Porcher, Isabelle Boutron, Amélie Yavchitz, Mehdi Benchoufi, Jean‐David Zeitoun, Agnès Dechartres and Jonathan C. Craig and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Perrine Créquit

39 papers receiving 700 citations

Peers

Perrine Créquit
Anup Amatya United States
Andrea Burton United Kingdom
Molly M. Neuberger United States
Lisa V. Hampson United Kingdom
Amr Makady Netherlands
Karen Crowell United States
Suzanne K. Linder United States
Asba Tasneem United States
Anup Amatya United States
Perrine Créquit
Citations per year, relative to Perrine Créquit Perrine Créquit (= 1×) peers Anup Amatya

Countries citing papers authored by Perrine Créquit

Since Specialization
Citations

This map shows the geographic impact of Perrine Créquit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perrine Créquit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perrine Créquit more than expected).

Fields of papers citing papers by Perrine Créquit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perrine Créquit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perrine Créquit. The network helps show where Perrine Créquit may publish in the future.

Co-authorship network of co-authors of Perrine Créquit

This figure shows the co-authorship network connecting the top 25 collaborators of Perrine Créquit. A scholar is included among the top collaborators of Perrine Créquit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perrine Créquit. Perrine Créquit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pons‐Tostivint, Elvire, Thomas Goronflot, Perrine Créquit, et al.. (2024). Second-line treatment outcomes following first-line chemotherapy plus immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC): A multicenter study.. Journal of Clinical Oncology. 42(16_suppl). e20122–e20122. 1 indexed citations
3.
Metelli, Silvia, Dimitris Mavridis, Perrine Créquit, & Anna Chaimani. (2023). Bayesian model-based outlier detection in network meta-analysis. Journal of the Royal Statistical Society Series A (Statistics in Society). 186(4). 754–771. 1 indexed citations
4.
Créquit, Perrine, Alexandre Vivot, Jules Grégory, & B. Milleron. (2022). Availability of results of academic randomized trials involving cooperative groups in oncology in France: A systematic search of clinical trial registries. Journal of Cancer Policy. 33. 100347–100347. 1 indexed citations
5.
Grégory, Jules, Perrine Créquit, Valérie Vilgrain, Maxime Ronot, & Isabelle Boutron. (2020). Results of trials assessing transarterial chemoembolization for treating hepatocellular carcinoma are critically underreported. European Radiology. 30(10). 5633–5640. 4 indexed citations
6.
Boutron, Isabelle, Perrine Créquit, Hywel C Williams, et al.. (2020). Future of evidence ecosystem series: 1. Introduction Evidence synthesis ecosystem needs dramatic change. Journal of Clinical Epidemiology. 123. 135–142. 29 indexed citations
7.
Ravaud, Philippe, Perrine Créquit, Hywel C Williams, et al.. (2020). Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem. Journal of Clinical Epidemiology. 123. 153–161. 31 indexed citations
8.
Grégory, Jules, Perrine Créquit, Valérie Vilgrain, Isabelle Boutron, & Maxime Ronot. (2020). Published trials of TACE for HCC are often not registered and subject to outcome reporting bias. JHEP Reports. 3(1). 100196–100196. 1 indexed citations
10.
Créquit, Perrine, et al.. (2018). Mapping of Crowdsourcing in Health: Systematic Review. Journal of Medical Internet Research. 20(5). e187–e187. 89 indexed citations
11.
Ruppert, Anne-Marie, James M. Perrin, Antoine Khalil, et al.. (2018). Effect of cannabis and tobacco on emphysema in patients with spontaneous pneumothorax. Diagnostic and Interventional Imaging. 99(7-8). 465–471. 16 indexed citations
12.
Yordanov, Youri, Agnès Dechartres, Ignacio Atal, et al.. (2018). Avoidable waste of research related to outcome planning and reporting in clinical trials. BMC Medicine. 16(1). 87–87. 40 indexed citations
13.
Lerner, Ivan, Perrine Créquit, Philippe Ravaud, & Ignacio Atal. (2018). Automatic screening using word embeddings achieved high sensitivity and workload reduction for updating living network meta-analyses. Journal of Clinical Epidemiology. 108. 86–94. 18 indexed citations
14.
Vivot, Alexandre, et al.. (2017). Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015. Annals of Oncology. 28(5). 1111–1116. 92 indexed citations
16.
Créquit, Perrine, Ludovic Trinquart, & Philippe Ravaud. (2016). Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor. BMJ Open. 6(8). e011841–e011841. 23 indexed citations
17.
Atsou, Kokuvi, Perrine Créquit, C. Chouaïd, & Gilles Hejblum. (2016). Simulation-Based Estimates of the Effectiveness and Cost-Effectiveness of Pulmonary Rehabilitation in Patients with Chronic Obstructive Pulmonary Disease in France. PLoS ONE. 11(6). e0156514–e0156514. 11 indexed citations
18.
Créquit, Perrine, et al.. (2014). Prise en charge des péricardites secondaires à un cancer broncho-pulmonaire. Revue des Maladies Respiratoires. 31(8). 746–753. 4 indexed citations
19.
Gounant, V., Antoine Khalil, Perrine Créquit, et al.. (2014). 2014 update on non-small cell lung cancer (excluding diagnosis). Diagnostic and Interventional Imaging. 95(7-8). 721–725. 4 indexed citations
20.
Créquit, Perrine, et al.. (2014). Traitement adjuvant des cancers bronchiques non à petite cellules : tolérance de l’association platine-pemetrexed. Revue des Maladies Respiratoires. 31(9). 817–821.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026